LUTS/BPH(구연) Oral Session 3 / LUTS/BPH (Ⅰ) (O-030) Crystal B (3F) 11월28일(수) 13:00-14:00 전립선비대증 환자에서 전립선결찰술의 임상적 효과: 국내 다기관 연구 1동남권원자력의학원 암센터 비뇨의학과 2동아대학교 의과대학 비뇨기과학교실 김정호¹, 이기수², 김태효² Purpose: The aim of this study was to assess the clinical outcomes of prostatic urethral lift in Korean patients with bothersome lower urinary tract system due to benign prostatic hyperplasia (BPH). Material and Methods: A total of 32 men with symptomatic BPH were consecutively treated at a tertiary care center in Korea. To be included in the present analysis, patients had to meet the following criteria: age≥50; International Prostatic Symptom Score (IPSS) > 12; and prostate volume between 30 mL and 80 mL.Patients were evaluated up to a median follow-up of 1 year postprocedure.The primary outcomes included symptom relief, improvement of quality of life (QOL), and preservation of sexual function. Result: All procedures were completed successfully with a mean of 2.2 implants without serious complication. The number of patients diagnosed with diabetes mellitus, hypertension, and ischemic heart disease were 16 (50%), 24 (75%), and 9 (28.1%), respectively (Table 1). Patients experienced symptom relief by 1 week that was sustained to 12 months. Mean IPSS, QOL, and maximum flow rate (Qmax) improved 43%, 70%, and 25% by 1 week, and 41%, 60%, and 32% ay 12 months (p<0.001), respectively (Table 2)(Figure 1-3). There were no occurrences of early urge incontinence, retrograde ejaculation, or erectile dysfunction. Adverse events were mild and transient. Conclusion: Prostatic urethral lift is a safe and effective treatment for BPH in Asian population. This treatment is minimal invasive, can be done under local anesthesia, and may be an appropriate method for fragile patients. keywords : benign prostatic hyperplasia, urolift, prostatic urethral lift